Home | Welcome to Contract Pharma   
Last Updated Saturday, September 20 2014
Print

Astellas Adds Executives



Published May 5, 2014
Related Searches: Pharma Regulatory Affairs Development
Bernhardt Zeiher, M.D. has been appointed executive vice president of Global Development at Astellas and Jeannette A. Barrett, Ph.D., has been named vice president and head of Medical Excellence, Global Medical Affairs.
 
Dr. Zeiher will be responsible for Global Development Operations and Global Clinical Pharmacology and Exploratory Development (GCPED), in addition to serving as therapeutic area head of Immunology, Infectious Disease, Transplant, Central Nervous System and Pain. He will continue to report to Dr. Sef Kurstjens, chief medical officer and president of Global Development. Dr. Zeiher has more than 15 years of experience in the pharma industry. Most recently he was vice president of the inflammation/immunology therapeutic area at Pfizer.

Dr. Barrett will be responsible for supporting medical affairs activities globally and providing the tools, processes, systems and infrastructure to ensure transparency, operational consistency, limit risk and improve compliance. Dr. Barrett will report to Dr. Charlotte Kremer, senior vice president and head, Global Medical Affairs. Dr. Barrett has more than 20 years of experience in the areas of medical affairs, regulatory affairs and drug safety having held leadership roles at several global pharmaceutical companies, including Pfizer, where she spent 16 years.
 
"Both Bernie and Jeannette's global experience, along with their pharmaceutical and clinical knowledge, make them perfect fits for Astellas," said Kurstjens. "We are delighted to be promoting Bernie and bringing Jeannette on to the Astellas team to further our mission of bringing important treatment options to patients."
 


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On